Victory Capital Management Inc Leap Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.39 - $2.84 $5,774 - $11,797	-4,154 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.06 - $2.94 $2,040 - $5,659	1,925 Added 86.36%	4,154 $7,000
Q4 2019 Feb 04, 2020	SELL	$0.63 - $1.37 $53 - $116	-85 Reduced 3.67%	2,229 $4,000
Q3 2019 Nov 12, 2019	BUY	$1.17 - $2.36 $2,707 - $5,461	2,314 New	2,314 $3,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $47.5M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.